APA (7th ed.) Citation

S, H., H, K., M, C., BH, K., S, C., & SG, L. (2026). Celecoxib potentiates ribociclib-induced apoptosis and anti-tumor activity by co-targeting COX-2/NF-κB and PI3K/AKT/mTOR pathways in hormone receptor-positive/HER2-negative breast cancer. Apoptosis : an international journal on programmed cell death, 31(5), . https://doi.org/10.1007/s10495-026-02340-z

Chicago Style (17th ed.) Citation

S, Han, Kim H, Choi M, Kim BH, Chae S, and Lee SG. "Celecoxib Potentiates Ribociclib-induced Apoptosis and Anti-tumor Activity by Co-targeting COX-2/NF-κB and PI3K/AKT/mTOR Pathways in Hormone Receptor-positive/HER2-negative Breast Cancer." Apoptosis : An International Journal on Programmed Cell Death 31, no. 5 (2026). https://doi.org/10.1007/s10495-026-02340-z.

MLA (9th ed.) Citation

S, Han, et al. "Celecoxib Potentiates Ribociclib-induced Apoptosis and Anti-tumor Activity by Co-targeting COX-2/NF-κB and PI3K/AKT/mTOR Pathways in Hormone Receptor-positive/HER2-negative Breast Cancer." Apoptosis : An International Journal on Programmed Cell Death, vol. 31, no. 5, 2026, https://doi.org/10.1007/s10495-026-02340-z.